Meridian Bioscience, Inc.
- Country
- 🇺🇸United States
- Ownership
- Holding, Public
- Established
- 1977-01-01
- Employees
- 515
- Market Cap
- -
Show Equivalence of the Modified BreathID Compared to Currently Approved BreathID in H.Pylori Detection
- Conditions
- Suspicion of Being Infected With H.Pylori
- Interventions
- Device: Modified BreathID
- First Posted Date
- 2012-07-26
- Last Posted Date
- 2022-12-20
- Lead Sponsor
- Meridian Bioscience, Inc.
- Target Recruit Count
- 113
- Registration Number
- NCT01650831
- Locations
- 🇺🇸
Unimed Center, East Brunswick, New Jersey, United States
Detection of Hepatocellular Carcinoma (HCC) With Octanoate Breath ID Test Compared to MRI
- Conditions
- Chronic Liver DiseaseHepatocellular Carcinoma (HCC)
- Interventions
- Drug: 13C Sodium Octanoate
- First Posted Date
- 2011-09-13
- Last Posted Date
- 2022-12-20
- Lead Sponsor
- Meridian Bioscience, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT01433016
- Locations
- 🇨🇦
Toronto General Hospital, Toronto, Ontario, Canada
BreathID® Test: A Non-invasive Modality to Detect Pancreatic Exocrine Insufficiency
- Conditions
- Chronic PancreatitisHealthy Volunteers
- Interventions
- Drug: benzoyl-L-tyrosyl-[1-13C]alanine (Bz-Tyr-Ala)
- First Posted Date
- 2010-12-14
- Last Posted Date
- 2022-12-20
- Lead Sponsor
- Meridian Bioscience, Inc.
- Target Recruit Count
- 33
- Registration Number
- NCT01259544
- Locations
- 🇮🇳
Asian Institute of Gastroenterology, Hyderabad, India, Somajiguda, Hyderabad, India
13-C Urea Breath Test Using BreathID System and PPIs (Proton Pump Inhibitors)
- Conditions
- Helicobacter Pylori Infection
- Interventions
- Drug: Omeprezole (Losec)Drug: Pantoprazole(Controloc)
- First Posted Date
- 2009-01-21
- Last Posted Date
- 2022-12-20
- Lead Sponsor
- Meridian Bioscience, Inc.
- Target Recruit Count
- 123
- Registration Number
- NCT00825630
- Locations
- 🇮🇱
Rabin Medical Center, Petah Tikva, Israel
BreathID 13C-Methacetin Breath Test for Detecting Cirrhosis
- Conditions
- Chronic Liver Disease
- Interventions
- Device: c13 methacetin solution with breath analyzer
- First Posted Date
- 2008-08-18
- Last Posted Date
- 2023-01-12
- Lead Sponsor
- Meridian Bioscience, Inc.
- Target Recruit Count
- 414
- Registration Number
- NCT00736840
- Locations
- 🇮🇱
Carmel Medical Center, Haifa, Israel
🇮🇱Soroka Medical Center, Beer Sheba, Israel
🇮🇱Hadassah Medical Center, Jerusalem, Israel
Breath Test to Assess Hepatic Metabolic Reserve and to Predict Hepatic Decompensation in Cirrhotics
- Conditions
- Cirrhosis
- First Posted Date
- 2006-09-12
- Last Posted Date
- 2022-12-20
- Lead Sponsor
- Meridian Bioscience, Inc.
- Target Recruit Count
- 200
- Registration Number
- NCT00375011
- Locations
- 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States
🇺🇸Department of Veteran Affairs, Richmond, Virginia, United States
🇮🇱Hadassah Medical Organization, Jerusalem, Israel
BreathID Multi-center HCV Liver Breath Test Study
- Conditions
- Hepatitis C
- Interventions
- Other: MBT and BreathID
- First Posted Date
- 2006-07-11
- Last Posted Date
- 2022-12-20
- Lead Sponsor
- Meridian Bioscience, Inc.
- Target Recruit Count
- 75
- Registration Number
- NCT00350714
- Locations
- 🇺🇸
U.S. Dept. of Veteran Affairs, Hunter Holmes McGuire Medical Center, Richmond, Virginia, United States
🇺🇸Mount Sinai School of Medicine, New York, New York, United States
🇺🇸Virginia Commonwealth Univeristy, Richmond, Virginia, United States